265 related articles for article (PubMed ID: 9266222)
1. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
[TBL] [Abstract][Full Text] [Related]
2. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
[TBL] [Abstract][Full Text] [Related]
3. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.
Manning NJ; Olpin SE; Pollitt RJ; Webley J
J Inherit Metab Dis; 1990; 13(1):58-68. PubMed ID: 2109149
[TBL] [Abstract][Full Text] [Related]
4. [Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in 2 patients with symptoms of Reye syndrome].
Brus F; Smit GP; Knoester H; Reijngoud DJ
Tijdschr Kindergeneeskd; 1988 Jun; 56(3):132-7. PubMed ID: 3046055
[TBL] [Abstract][Full Text] [Related]
5. Detection and quantitation of acylcarnitines in plasma and blood spots from patients with inborn errors of fatty acid oxidation.
Schmidt-Sommerfeld E; Penn D; Duran M; Rinaldo P; Bennett MJ; Santer R; Stanley CA
Prog Clin Biol Res; 1992; 375():355-62. PubMed ID: 1438381
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
Deschamps D; Fisch C; Fromenty B; Berson A; Degott C; Pessayre D
J Pharmacol Exp Ther; 1991 Nov; 259(2):894-904. PubMed ID: 1941634
[TBL] [Abstract][Full Text] [Related]
7. Acylcarnitines in the urine of a patient with medium chain acyl-CoA dehydrogenase (MCAD) deficiency and in normal children.
Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL
Prog Clin Biol Res; 1990; 321():403-9. PubMed ID: 2326301
[No Abstract] [Full Text] [Related]
8. Impact of newborn screening for fatty acid oxidation disorders on neurological outcome: A Belgian retrospective and multicentric study.
Everard E; Laeremans H; Boemer F; Marie S; Vincent MF; Dewulf JP; Debray FG; De Laet C; Nassogne MC
Eur J Paediatr Neurol; 2024 Mar; 49():60-65. PubMed ID: 38377647
[TBL] [Abstract][Full Text] [Related]
9. [Carnitine deficiency].
Schmidt-Sommerfeld E; Penn D
Monatsschr Kinderheilkd; 1986 May; 134(5):224-31. PubMed ID: 3014317
[TBL] [Abstract][Full Text] [Related]
10. Abnormal 13C-fatty acid breath tests in patients treated with valproic acid.
Arimoto K; Sakuragawa N; Suehiro M; Watanabe H
J Child Neurol; 1988 Oct; 3(4):250-7. PubMed ID: 3143757
[TBL] [Abstract][Full Text] [Related]
11. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.
Treem WR; Stanley CA; Goodman SI
J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671
[TBL] [Abstract][Full Text] [Related]
12. Effect of fatty acids and their derivatives on mitochondrial structures.
Singh AK; Yoshida Y; Garvin AJ; Singh I
J Exp Pathol; 1989; 4(1):9-15. PubMed ID: 2778551
[TBL] [Abstract][Full Text] [Related]
13. [Alterations of mitochondria in metabolic diseases. Carnitine deficiency, carnitine palmitoyltransferase deficiency and beta oxidation].
Angelini C
Acta Neurol (Napoli); 1989 Oct; 11(5):330-4. PubMed ID: 2603779
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of medium-chain acyl-CoA dehydrogenase deficiency in lymphocytes and liver by a gas chromatographic method: the effect of oral riboflavin supplementation.
Duran M; Cleutjens CB; Ketting D; Dorland L; de Klerk JB; van Sprang FJ; Berger R
Pediatr Res; 1992 Jan; 31(1):39-42. PubMed ID: 1594328
[TBL] [Abstract][Full Text] [Related]
15. Myopathies caused by disorders of lipid metabolism.
Carroll JE
Neurol Clin; 1988 Aug; 6(3):563-74. PubMed ID: 3065601
[TBL] [Abstract][Full Text] [Related]
16. Decreased fasting free fatty acids with L-carnitine in children with carnitine deficiency.
Schwenk WF; Hale DE; Haymond MW
Pediatr Res; 1988 May; 23(5):491-4. PubMed ID: 3290828
[TBL] [Abstract][Full Text] [Related]
17. Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy.
DiDonato S; Gellera C; Peluchetti D; Uziel G; Antonelli A; Lus G; Rimoldi M
Ann Neurol; 1989 May; 25(5):479-84. PubMed ID: 2774489
[TBL] [Abstract][Full Text] [Related]
18. Short-chain acyl-CoA dehydrogenase deficiency.
Turnbull DM; Shepherd IM; Bartlett K; Sherratt HS
Prog Clin Biol Res; 1990; 321():313-24. PubMed ID: 2326296
[No Abstract] [Full Text] [Related]
19. Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine.
Rinaldo P; O'Shea JJ; Coates PM; Hale DE; Stanley CA; Tanaka K
N Engl J Med; 1988 Nov; 319(20):1308-13. PubMed ID: 3054550
[TBL] [Abstract][Full Text] [Related]
20. A murine model for short-chain acyl-CoA dehydrogenase deficiency.
Wood PA; Amendt BA; Rhead WJ; Armstrong D; Millington DS; Inoue F
Prog Clin Biol Res; 1990; 321():427-34. PubMed ID: 2326304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
